Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Mental Health Clinical Trials Market Expected To Become By 2029 Compared With Its 2025 Level?
The mental health clinical trials market has shown strong growth in recent years. It is projected to increase from $2.96 billion in 2024 to $3.23 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.1%. This historical expansion can be linked to a rising interest in neuropsychiatric drug development, an increase in rates of stress, anxiety, and depression, enhanced support from government and regulatory bodies, the growing geriatric population, and an escalating demand for non-pharmacological interventions.
The mental health clinical trials market is projected to experience substantial expansion in the coming years. By 2029, this market is anticipated to reach a valuation of $4.51 billion, expanding at a compound annual growth rate (CAGR) of 8.7%. Factors contributing to this growth over the forecast period include the escalating prevalence of mental health disorders, heightened awareness surrounding mental health issues, an expanding demand for personalized medicine, increasing healthcare expenditure, and the broader adoption of digital health technologies. Key trends expected during the forecast period encompass progress in digital health platforms, technological developments in wearable devices, advancements in neuroimaging technologies, developments in electronic data capture (EDC) systems, and the emergence of technology-driven decentralized clinical trial models.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27343&type=smp
What Are The Key Drivers Of Growth In The Mental Health Clinical Trials Market?
The increasing occurrence of mental health conditions is projected to drive the expansion of the mental health clinical trials market moving forward. Mental health disorders are defined as illnesses that significantly influence an individual’s feelings, thoughts, actions, and overall psychological health. The escalation of these disorders is linked to growing stress from modern living, including occupational pressures, social isolation, and constant digital connectivity. Mental health clinical trials contribute to advancements in care by evaluating the safety and effectiveness of new medications, therapies, and behavioral interventions for mental health issues. For instance, in May 2024, the American Psychiatric Association, a US-based non-profit organization, reported that, in 2024, around 43% of adults in the USA were feeling more anxious, an increase from 37% in 2023 and 32% in 2022. Therefore, the rising prevalence of mental health disorders is driving the growth of the mental health clinical trials market.
Which Key Segments Fueling The Mental Health Clinical Trials Market?
The mental health clinical trials market covered in this report is segmented
1) By Phase: Phase I, Phase II, Phase III, Phase IV
2) By Study Design: Interventional, Observational, Other Study Designs
3) By Disorder: Anxiety Disorders, Depression, Bipolar Affective Disorder, Dissociation And Dissociative Disorders, Schizophrenia, Other Disorders
4) By Sponsor: Pharmaceutical And Biopharmaceutical Companies, Government Agencies, Other Sponsors
Subsegments:
1) By Phase I: Single Ascending Dose, Multiple Ascending Dose, First In Human, Pharmacokinetics Studies
2) By Phase II: Dose Ranging Studies, Proof Of Concept Studies, Randomized Controlled Trials, Open Label Studies
3) By Phase III: Large Scale Randomized Trials, Multicenter Studies, Comparative Effectiveness Trials, Double Blind Studies
4) By Phase IV: Post Marketing Surveillance, Long Term Safety Studies, Real World Evidence Studies, Pharmacovigilance Studies
What Key Innovation Trends Are Fueling Advancements In The Mental Health Clinical Trials Market?
Leading companies in the mental health clinical trials market are prioritizing the development of advanced interventions, such as adjunctive therapies, to enhance effectiveness, improve patient outcomes, and address unresolved needs in mental health conditions. Adjunctive therapies refer to medications utilized alongside primary treatments to boost their efficacy in managing complex ailments. For instance, in December 2022, AbbVie Inc., a US-based biopharmaceutical firm, secured U.S. Food and Drug Administration (FDA) approval for VRAYLAR (cariprazine) as an additional therapy for major depressive disorder in adults. VRAYLAR employs a unique dopamine-serotonin partial agonist mechanism that supplements conventional antidepressants. It assists in alleviating depressive symptoms in patients who have not responded adequately to standard treatments. The product also contributes to better mood stabilization while lessening adverse effects often observed with older antipsychotics.
Which Global Market Leaders Are Shaping The Future Of The Mental Health Clinical Trials Sector?
Major companies operating in the mental health clinical trials market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., IQVIA Holdings Inc., Biogen Inc., ICON plc., Parexel International Corporation, CMIC Holdings Co. Ltd., Medpace Holdings Inc., PSI CRO AG., Supernus Pharmaceuticals Inc., Worldwide Clinical Trials, Inc., Ergomed, Celerion Inc., Biotrial S.A.S., Lindus Health Ltd., Novotech Health Holdings Pte Ltd., Precision for Medicine Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/mental-health-clinical-trials-global-market-report
What Regional Growth Trends Are Shaping The Mental Health Clinical Trials Market Outlook?
North America was the largest region in the mental health clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mental health clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Mental Health Clinical Trials Market Report:
https://www.thebusinessresearchcompany.com/customise?id=27343&type=smp
Browse Through More Reports Similar to the Global Mental Health Clinical Trials Market 2025, By The Business Research Company
Aircraft Elevator Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/aircraft-elevator-global-market-report
Elevator And Escalator Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/elevator-and-escalator-global-market-report
Smart Elevators Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/smart-elevators-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model